Status:
COMPLETED
Effect of Aging on Haemostasis Parameters
Lead Sponsor:
Hopital Lariboisière
Conditions:
Aging
Eligibility:
All Genders
40+ years
Brief Summary
Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.
Detailed Description
Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolys...
Eligibility Criteria
Inclusion
- age \<40 2 groups : 1 : no history of VTE 2 : history of VTE
Exclusion
- antiaggregant or anticoagulant therapy at curative dose
- arterial or thrombotic event in the last month
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00299624
Start Date
October 1 2005
End Date
August 1 2006
Last Update
September 14 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Lariboisiere
Paris, France, 75010
2
Hopital Lariboisière
Paris, France, 75010